(PRESSWIRE) - Two new meta studies published in the Journal Nature, one authored by Dr. David Gems, and the second one by Drs. Auwerx and Canto, examine previous studies of red wine's ability to promote human health and longevity. The compound which is contained in red wine which was the subject of the study is called resveratrol. Resveratrol specialist James Betz of Biotivia, a biotech company involved in the study of this compound commented on the two studies. Resveratrol was first identified as an activator of enzymes known as sitruins by Dr David Sinclair of Harvard and his work was also published in the prestigious journal Nature in 2006. Since that time over 5,000 additional studies of resveratrol have been undertaken. The vast majority of these studies elucidate impressive potential health benefits of the red wine molecule. Although most of these studies were done on animals or in the lab, since 2009 a significant number, using a purified form of resveratrol called transmax resveratrol, have been done on human subjects. In these clinical trials resveratrol was shown to improve blood glucose tolerance in pre diabetic subjects, increase brain blood flow in university students, increase fitness in both training and sedentary subjects and to have a wide range of other beneficial health effects.